In the News

Share
1731 News Items found
Feature
The Paul Marks Prize medal
The 3 Winners of MSK’s 2023 Paul Marks Prize for Cancer Research Will Present Their Research at Symposium
The three recipients of the 2023 Paul Marks Prize for Cancer Research will present their research at a symposium. Learn about the research of Mark Agnel Frederick Dawson, Cigall Kadoch, and Michelle Monje,
In the Clinic
Man with wife and three sons.
How Robotic Surgery for Colorectal Cancer Can Reduce Side Effects
MSK performs the highest number of robot-assisted surgeries for colorectal cancer in the United States, enabling more patients to have a shorter hospital stay and a faster recovery.
Feature
Dennis Flaherty
How MSK Is Helping Dennis Survive Stage 4 Kidney Cancer
When Dennis Flaherty was diagnosed with stage 4 kidney cancer, he knew he wanted to be treated at MSK. His story illustrates why U.S. News & World Report ranked MSK the top hospital in the country for urology care in 2023.
Rosario Costas-Muñiz, PhD, is a psychologist whose work focuses on the Latino community at Memorial Sloan Kettering.
Helping Latinos Prevent Colon Cancer: Good News about Screening
Learn from an MSK specialist in cancer care for the Latino community about screening for colorectal cancer, which can help prevent the disease.
Feature
Vittoria Bocchi, Melissa Yao, Julia Brunner, and Tzippora Chwat-Edelstein
Meet the 4 Winners of the 2024 Kravis WiSE Fellowships
MSK is proud to announce that four Sloan Kettering Institute (SKI) researchers have been named 2024 Marie-Josée Kravis Women in Science Endeavor (Kravis WiSE) fellowship grant recipients.
MSK clinical psychologist Dr. Allison Applebaum
Advance Care Planning Advice for Family Caregivers
Read advice from an MSK clinical psychologist about how caregivers of people with cancer can best manage their emotions and life responsibilities.
Feature
Drs. Alina Markova, Michael Scordo, Vinod Balachandran, Katharine Hsu, Tobias Hohl, and Sandeep Raj
MSK Experts Present Research at Bone Marrow Transplant and Cellular Therapy Meeting 
Researchers from MSK presented findings on graft-versus-host disease and other topics at the annual meeting of bone marrow transplant and cellular therapy experts.
MSK helped Roberto Romero’s immune system grow an army of T cells to fight melanoma using TIL therapy, which offers new hope against solid tumors.
How MSK Used TIL Therapy To Treat Melanoma in Roberto
Learn how MSK uses TIL therapy for melanoma — the first cell therapy approved by the FDA to treat a solid tumor.
detail shot of a microscope in an MSK lab
MSK Research Highlights, February 12, 2024
New research from MSK investigates overcoming drug resistance in chronic lymphocytic leukemia; describes a new method for identifying driver mutations in tumor samples; identifies a protein that orchestrates macrophages’ cancer-fighting abilities; and uncovers how cancer programs could do more to help patients quit smoking.
MSK physician-scientist Alex Kentsis
Epigenetic Combination Therapy Could Overcome Treatment Resistance in Epithelioid Sarcomas and Rhabdoid Tumors
Learn about a possible new treatment approach for soft tissue sarcomas.